Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
TEVIMBRA Inf Konz 100 mg/10ml Durchstf
Drug
Tevimbra, Konzentrat zur Herstellung einer Infusionslösung
Onkologikum
07.16.1. – cytostatics
HAM – Human medicine
KOINF – Concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
4/11/2024
4/10/2029
Dosage strength
Tevimbra, 100 mg / 10 ml Konzentrat zur Herstellung einer Infusionslösung
Onkologikum
01
Z – approved
Package
8720598340273
No information made available
A/R – Authorised / referenced
vial(s)
001
Z – approved
Declaration
Component
100 mg tislelizumabum
natrii citras dihydricus
acidum citricum monohydricum
histidini hydrochloridum monohydricum
histidinum
trehalosum dihydricum
polysorbatum 20
aqua ad iniectabile
16 mg natrium
acidum citricum monohydricum
histidini hydrochloridum monohydricum
histidinum
trehalosum dihydricum
polysorbatum 20
aqua ad iniectabile
16 mg natrium
Spezialitätenliste***
SL
-
-
1991.60
None
Yes
10%
No
Authorisation holder
7601002995795
BeiGene Switzerland GmbH
Aeschengraben 27
4051 Basel (BS)
Aeschengraben 27
4051 Basel (BS)
Date of revision of the text
11/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.